The Food and Drug Administration today updated its webpage on the performance of SARS-CoV-2 serology tests authorized for emergency use to help health care providers interpret these antibody test results for their patients. The update also clarifies the use of serology tests when assessing a patient’s adaptive immune response. 

Related News Articles

Headline
The Centers for Medicare & Medicaid Services Office of Minority Health will host a May 13 webinar on building COVID-19 vaccine confidence. Register for the…
Headline
 A Centers for Disease Control and Prevention assessment affirms the ability of the two authorized mRNA COVID-19 vaccines to prevent hospitalization…
Headline
The Centers for Disease Control and Prevention today announced relaxed guidance for mask wearing, stating that individuals fully vaccinated against COVID-19 no…
Headline
An independent Centers for Disease Control and Prevention advisory committee today recommended immediate resumption of the administration of Johnson &…
Headline
The Food and Drug Administration April 16 revoked the emergency use authorization that allowed for the investigational monoclonal antibody therapy bamlanivimab…
News
The Food and Drug Administration today revoked the emergency use authorization that allowed for the investigational monoclonal antibody therapy bamlanivimab,…